Plasminogen promotes sarcoma growth and suppresses the accumulation of tumor-infiltrating macrophages

被引:21
作者
Curino, A
Mitola, DJ
Aaronson, H
McMahon, GA
Raja, K
Keegan, AD
Lawrence, DA
Bugge, TH
机构
[1] Natl Inst Dent Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA
[2] Amer Red Cross, Dept Immunol, Rockville, MD 20855 USA
[3] Amer Red Cross, Dept Vasc Biol, Rockville, MD 20855 USA
关键词
fibrosarcoma; tumor-infiltrating macrophages; plasminogen activator; stroma;
D O I
10.1038/sj.onc.1205951
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specific functions of plasminogen, stromal plasminogen activator, stromal plasminogen activator receptor, and stromal plasminogen activator inhibitor in the progression of the murine soft tissue sarcoma, T241 were investigated. Negation of plasminogen to the tumor blunted the orthotopic growth of the sarcoma in syngeneic mice. The reduced tumor growth was associated with a dramatic increase in tumor-infiltrating F4/80-positive macrophages and a diminution of vessel density, but not with obvious differences in fibrin and collagen deposition, or invasiveness of the tumor. Ablation of plasminogen activation by the tumor stroma only modestly impaired the prolonged growth of the sarcoma, suggesting that tumor cell-produced plasminogen activator is sufficient to mediate productive plasminogen activation. Plasminogen facilitated sarcoma progression, angiogenesis, and suppression of macrophage infiltration in the absence of either stromal urokinase plasminogen activator receptor or stromal plasminogen activator inhibitor. These data demonstrate that tumor cell-produced plasminogen activator and host plasminogen cooperate to facilitate soft tissue sarcoma growth and suppress the accumulation of tumor-infiltrating macrophages.
引用
收藏
页码:8830 / 8842
页数:13
相关论文
共 117 条
  • [1] ALLEVA DG, 1994, J IMMUNOL, V153, P1674
  • [2] Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
  • [3] 2-Z
  • [4] The plasminogen activation system in tumor growth, invasion, and metastasis
    Andreasen, PA
    Egelund, R
    Petersen, HH
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) : 25 - 40
  • [5] Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
    Bajou, K
    Noël, A
    Gerard, RD
    Masson, V
    Brunner, N
    Holst-Hansen, C
    Skobe, M
    Fusenig, NE
    Carmeliet, P
    Collen, D
    Foidart, JM
    [J]. NATURE MEDICINE, 1998, 4 (08) : 923 - 928
  • [6] BAKER MS, 1990, CANCER RES, V50, P4676
  • [7] Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice
    Beck, JM
    Preston, AM
    Gyetko, MR
    [J]. INFECTION AND IMMUNITY, 1999, 67 (02) : 879 - 884
  • [8] The urokinase receptor. A cell surface, regulated chemokine
    Blasi, F
    [J]. APMIS, 1999, 107 (01) : 96 - 101
  • [9] POLYMORPHISMS IN THE CODING AND NONCODING REGIONS OF MURINE PGK-1 ALLELES
    BOER, PH
    POTTEN, H
    ADRA, CN
    JARDINE, K
    MULLHOFER, G
    MCBURNEY, MW
    [J]. BIOCHEMICAL GENETICS, 1990, 28 (5-6) : 299 - 308
  • [10] Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
    Bugge, TH
    Flick, MJ
    Danton, MJS
    Daugherty, CC
    Romer, J
    Dano, K
    Carmeliet, P
    Collen, D
    Degen, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 5899 - 5904